News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Forest Laboratories, Inc. (FRX) To Present Data About Aclidinium, Aclidinium/Formoterol Combination, And Roflumilast At The American Thoracic Society International Conference


5/19/2014 6:42:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Forest Laboratories, Inc. (NYSE:FRX) today announced that it will present data on aclidinium, aclidinium/formoterol combination, and roflumilast at the American Thoracic Society (ATS) 2014 International Conference scheduled for May 16-21, 2014, in San Diego. Ten posters and two poster discussion sessions will be presented for aclidinium and aclidinium/formoterol. Roflumilast data will be highlighted in four posters and one mini symposia presentation.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES